Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Quercetin  COVID-19 treatment studies for Quercetin  C19 studies: Quercetin  Quercetin   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest
Wu et al., Molecular Therapy, doi:10.1016/j.ymthe.2022.12.002
Wu et al., Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent.., Molecular Therapy, doi:10.1016/j.ymthe.2022.12.002
Dec 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Mouse study showing quercetin can significantly inhibit SARS-CoV-2 induced acute kidney injury via blocking of SARS-CoV-2 N-Smad3-mediated cell death.
Wu et al., 12 Dec 2022, China, peer-reviewed, 9 authors.
Contact: hylan@cuhk.edu.hk, yuxueqing@gdph.org.cn, wangxiao773@hotmail.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperQuercetinAll
Abstract: Journal Pre-proof Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest Wenjing Wu, Wenbiao Wang, Liying Liang, Junzhe Chen, Biao Wei, Xiao-Ru Huang, Xiaoqin Wang, Xueqing Yu, Hui-Yao Lan PII: S1525-0016(22)00706-7 DOI: https://doi.org/10.1016/j.ymthe.2022.12.002 Reference: YMTHE 5967 To appear in: Molecular Therapy Received Date: 10 October 2022 Accepted Date: 8 December 2022 Please cite this article as: Wu W, Wang W, Liang L, Chen J, Wei B, Huang X-R, Wang X, Yu X, Lan H-Y, Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell cycle arrest, Molecular Therapy (2023), doi: https://doi.org/10.1016/ j.ymthe.2022.12.002. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2022 The American Society of Gene and Cell Therapy. Jo na ur re lP ro -p of 1 Treatment with Quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury 2 by blocking Smad3-dependent G1 cell cycle arrest 3 Wenjing Wu1,2,3,4, Wenbiao Wang1, Liying Liang2, Junzhe Chen2,5, Biao Wei2, Xiao-Ru 4 Huang1,2, Xiaoqin Wang3,4, Xueqing Yu1, and Hui-Yao Lan1,2 5 1. Guangdong-Hong Kong Joint Laboratory for Immunological and Genetic Kidney 6 Disease, Departments of Nephrology and Pathology, Guangdong Provincial People’s 7 Hospital, Guangdong Academy of Medical Science, Guangzhou, China. 2. Departments of Medicine & Therapeutics, Li Ka Shing Institute of Health Sciences, Lui 9 Che Woo Institute of Innovative Medicine, and The Chinese University of Hong Kong 10 (CUHK) - Guangdong Academy of Medical Sciences / Guangdong Provincial People’s 11 Hospital (GAMS/GPPH) Joint Research Laboratory on Immunological and Genetic 12 Kidney Diseases, The Chinese University of Hong Kong, Hong Kong, China. re -p r oo f 8 3. Hubei University of Chinese Medicine, Wuhan, China. 14 4. Department of Nephrology, Hubei Provincial Hospital of Traditional Chinese Medicine, 16 17 Hubei Province Academy of Traditional Chinese Medicine, Wuhan, China. ur na 15 lP 13 5. Department of Nephrology, The Third Affiliated hospital, Southern Medical University, Guangzhou, China. 18 Correspondence: Professor Hui-Yao Lan, Departments of Medicine & Therapeutics, Li Ka 20 Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China. 21 E-mail: hylan@cuhk.edu.hk; Professor Xueqing Yu, Guangdong Academy of Medical Science, 22 Guangdong 23 yuxueqing@gdph.org.cn; and Professor Xiaoqin Wang, Department of Nephrology, Hubei 24 Provincial Hospital of Traditional Chinese Medicine, Hubei Province Academy of Traditional 25 Chinese Medicine, Wuhan, China, E-mail: wangxiao773@hotmail.com Jo 19 Provincial People’s Hospital, 26 27 28 29 1 Guangzhou, China, E-mail : 30 31 32 Abstract Increasing evidence shows that SARS-CoV-2 can infect kidneys and cause acute kidney 34 injury..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit